Also, we uncovered the enrollment of PKC family members in regulating the tumor-associated immune cells aggregation with a special reference to the potential value of using the PKC family in predicting the immune landscape and the response to the immunotherapies in different cancers. This evidence concerns the gene PRRT2 and cancer.